MwanzoSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
$ 2.55
Baada ya Saa za Kazi:(3.14%)-0.080
$ 2.47
Imefungwa: 6 Jun, 20:00:00 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 3.25
Bei za siku
$ 2.23 - $ 3.12
Bei za mwaka
$ 1.90 - $ 8.92
Thamani ya kampuni katika soko
2.18M USD
Wastani wa hisa zilizouzwa
elfu 694.30
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | elfu 206.00 | — |
Matumizi ya uendeshaji wa biashara | 2.10M | 14.98% |
Mapato halisi | -2.23M | 4.29% |
Kiwango cha faida halisi | elfu -1.08 | — |
Mapato kwa kila hisa | — | — |
EBITDA | -1.76M | -1.44% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.96M | -59.67% |
Jumla ya mali | 13.45M | -23.03% |
Jumla ya dhima | 3.47M | -84.25% |
Jumla ya hisa | 9.98M | — |
hisa zilizosalia | elfu 853.00 | — |
Uwiano wa bei na thamani | 0.64 | — |
Faida inayotokana na mali | -44.01% | — |
Faida inayotokana mtaji | -48.58% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -2.23M | 4.29% |
Pesa kutokana na shughuli | -1.08M | 12.16% |
Pesa kutokana na uwekezaji | 0.00 | 100.00% |
Pesa kutokana na ufadhili | 2.00M | — |
Mabadiliko halisi ya pesa taslimu | elfu 926.00 | 162.86% |
Mtiririko huru wa pesa | elfu -222.50 | 93.07% |
Kuhusu
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Ilianzishwa
1 Jan 2003
Tovuti
Wafanyakazi
31